SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending downwards, with community members citing a potential overreaction and broader concerns about competition from Starlink following news of their Echostar spectrum acquisition. Some investors view the dip as a buying opportunity, while others express bearish sentiment and point to broken technical patterns. Discussions also revolve around upcoming launches, government contracts, and the company's long-term potential in the 5G D2D market.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors discuss the potential of its solid-state battery technology following news of its use in a Ducati motorcycle and PowerCo's focus on solid-state batteries at an upcoming mobility conference. Community members are debating the timeline for commercialization, potential partnerships, and the impact of recent insider selling. Some are drawing comparisons to competitors like Solid Power, while others express optimism about QuantumScape's long-term prospects and potential for disruption in the EV battery market.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's shares are surging as it has been added to the S&P 500, replacing Caesars Entertainment. The community is discussing the implications of this inclusion, with many expecting increased stability and potential for long-term growth as index funds are now forced buyers. Some traders anticipate a short squeeze and are setting price targets, while others remain cautious, citing potential profit-taking.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as community members rally behind the stock, fueled by enthusiasm and speculation of a potential short squeeze. Chatter revolves around a well-known comedian investing in the company, with retail traders expressing bullish sentiment and anticipating further gains. The stock is also gaining traction as a potential turnaround story within the real estate sector.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors anticipate upcoming earnings, with community chatter focused on potential profitability and the impact of new ventures like trading cards. Some traders express frustration with the stock's sideways movement, while others debate whether to expect a pre-earnings run-up or a post-earnings dump. The stock is also being compared to other meme stocks and those with short squeezes.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a recently announced land sale, potentially boosting its NAV and sparking interest in its low float. The community is actively discussing potential breakouts and comparing it to other recent low-float runners, while also debating the merits of its liquidation strategy. Chatter revolves around potential for a significant price increase, with some eyeing specific breakout levels.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending due to the company's announcement of the Phase 3 study of eRapa in FAP, generating excitement around its potential. The community is actively discussing the company's low float and high short interest, speculating about a potential short squeeze. Some traders are also weighing in on the stock's history of reverse splits and volatility.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending due to a revenue beat, positive free cash flow, and significant backlog growth fueled by contracts with NATO, the German government, and the U.S. DoD. The community is discussing the company's strategic position in defense and security markets, as well as the potential for AI-enabled solutions leveraging their proprietary data.

Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.

Forward Industries, Inc.

Forward Industries (FORD) is trending due to a significant $1.65B private placement to initiate a Solana treasury strategy, sparking community interest and high trading volume.  The small float is fueling volatility, with some traders mistaking it for Ford Motor Company (F), while others are closely watching for potential short squeezes and parabolic movement similar to other low-float runners. Concerns about the company's fundamentals and potential scams are also being discussed.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapport Therapeutics ($RAPP) is trending following the release of positive topline results from its Phase 2a clinical trial for RAP-219 in patients with focal onset seizures, showing significant seizure reduction; this has sparked excitement around the company's precision neuroscience platform. Community discussions revolve around the potential for a squeeze, resistance levels, and whether the data warrants the recent price action, with some noting the relatively small float of 34 million.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbbVie Completes Acquisition of Landos Biopharma

AbbVie Completes Acquisition of Landos Biopharma AbbVie Completes Acquisition of Landos Biopharma PR Newswire NORTH CHICAGO, Ill., May 23, 2024 - Adds first-in-class investigational asset, NX-13, to...

LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Landos Biopharma, Inc. (NasdaqCM: LABP) to...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX PR Newswire NEW YORK, April 18, 2024 NEW...

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT PR Newswire NEW YORK, April 9, 2024 NEW YORK, April...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA PR Newswire NEW YORK, April 5, 2024 NEW YORK, April...

HC Wainwright Reiterates Neutral Rating for Landos Biopharma (NASDAQ:LABP)

Landos Biopharma (NASDAQ:LABP - Get Free Report)s stock had its "neutral" rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

Maintaining Hold Rating on Landos Biopharma Amid Acquisition by AbbVie and Limited Upside Potential

Landos Biopharma (LABP Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from...

Landos Biopharma just downgraded at H.C. Wainwright, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway. The firm's preclinical candidates include LABP-73, LABP-66, and LABP-69. The company was founded by Josep Bassaganya-Riera in January 2017 and is headquartered in Blacksburg, VA.

LABP
Landos Biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest LABP News

LABP Landos Biopharma Inc